Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Adelie
ParisSeed–Growth$2.2M – $10.8M
8 people
Shaping Impact Group
BrusselsPre-Seed–Series A$270K – $1.6M
20 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $5M
19 people
Mount Judi Ventures
BengaluruPre-Seed–Series B
16 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Tenmile
Seed–Series B
11 people
EFung Capital
ShenzhenSeries A–Growth
IDL Ventures
ChicagoSeed–Series A
21 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
12 people
NovaCapital
Seed–Late Stage
9 people
Shackleton Ventures Ltd.
LondonSeed–Series A$952.5K – $25.4M
6 people
Heliad AG
Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M
14 people
Naples Technology Ventures
NaplesSeed–Series A
11 people
HTwenty
MiamiPre-Seed–Series A$100K – $1M
7 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Fluent Ventures
Mill ValleyPre-Seed–Series A$250K – $2M
9 people
GSR United Capital
BeijingSeed–Growth
APERTURE Venture Partners
New YorkSeed–Series C$1M – $5M
4 people
True Wealth Ventures
AustinSeed–Series A$1M
10 people
Meridian Street Capital
New YorkPre-Seed–Series A$100K – $5M
6 people
Smilegate Investment
SeoulSeed–Series B$500K
15 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.

























































































